200 related articles for article (PubMed ID: 32036480)
1. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
Morita M; Taguchi K; Kagawa M; Nakanoko T; Uehara H; Sugiyama M; Ota M; Ikebe M; Sugimachi K; Esaki T; Toh Y
Int J Clin Oncol; 2020 May; 25(5):842-850. PubMed ID: 32036480
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
3. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
4. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
Chen J; Wang A; Ji K; Bu Z; Ji J
BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
[TBL] [Abstract][Full Text] [Related]
6. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
8. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
[TBL] [Abstract][Full Text] [Related]
9. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine carcinoma of the gastric stump: A case report and literature review.
Ma FH; Xue LY; Chen YT; Xie YB; Zhong YX; Xu Q; Tian YT
World J Gastroenterol; 2018 Jan; 24(4):543-548. PubMed ID: 29398875
[TBL] [Abstract][Full Text] [Related]
11. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma.
Deng HY; Li G; Luo J; Li XR; Alai G; Lin YD
World J Surg; 2018 Aug; 42(8):2428-2436. PubMed ID: 29340724
[TBL] [Abstract][Full Text] [Related]
12. [Perioperative therapy in esophageal and stomach carcinoma].
Stahl M; Wilke H; Meyer HJ
Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
[No Abstract] [Full Text] [Related]
13. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.
Rüdiger Siewert J; Feith M; Werner M; Stein HJ
Ann Surg; 2000 Sep; 232(3):353-61. PubMed ID: 10973385
[TBL] [Abstract][Full Text] [Related]
15. [Two case reports of neuroendocrine cell carcinoma of the stomach].
Chohno T; Kobayashi K; Aoki T; Nishioka K; Takachi K; Hyuga S; Watanabe R; Kato A; Komori T; Matsumoto T; Uemura Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1895-7. PubMed ID: 23267922
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases.
Egashira A; Morita M; Kumagai R; Taguchi KI; Ueda M; Yamaguchi S; Yamamoto M; Minami K; Ikeda Y; Toh Y
PLoS One; 2017; 12(3):e0173501. PubMed ID: 28288180
[TBL] [Abstract][Full Text] [Related]
17. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification.
Endo S; Dousei T; Yoshikawa Y; Hatanaka N; Taniyama K; Yamauchi A; Kamiike W; Nishijima J
Int Surg; 2012; 97(4):335-9. PubMed ID: 23294075
[TBL] [Abstract][Full Text] [Related]
18. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
19. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma.
Cabau M; Luc G; Terrebonne E; Belleanne G; Vendrely V; Sa Cunha A; Collet D
Am J Surg; 2013 Jun; 205(6):711-7. PubMed ID: 23422318
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
